Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)

Written by Petra Hegmann on 11th March 2019. Posted in Client News.

• Previous
• Next